IncFact
Company Profiles: Revenue, Growth, Competition

ALNYLAM PHARMACEUTICALS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Alnylam Pharmaceuticals

Access the complete profile.

Alnylam Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
541711 Research & Development in Biotechnology
Address300 3rd Street, 3rd Floor
Cambridge, MA 02142

www.alnylam.com


Alnylam Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Scientific Research & Development Services industry.


Alnylam Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Alnylam Pharmaceuticals is a publicly traded company on NMS using the ticker symbol ALNY. Detailed information on company financials and operating reports can be found here: NMS: ALNY



Alnylam Pharmaceuticals Annual Revenue and Growth Rate

Alnylam Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Alnylam Pharmaceuticals's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Alnylam Pharmaceuticals is developing and marketing. Alnylam Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
AMVYTTRA
Pharmaceutical preparations for the treatment of amyloidosis
09/15/2020
AMVUTTRA
Pharmaceutical preparations for the treatment of amyloidosis
09/01/2020
RNAI EVIDENCE
Maintaining a clinical registry database for patients with genetic mutations; maintaining a registry on the clinical outcomes in patients over time
08/28/2020

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Alnylam Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Alnylam Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Alnylam Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Alnylam Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
OMNICARECincinnati, OH100 
LEIDOSReston, VA91 
INC RESEARCHMorrisville, NC62 
SCIENCE APPLICATIONS INTERNATIONALReston, VA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM47 
CEPHALONFrazer, PA44 
SYNEOS HEALTHRaleigh, NC29 
INCYTEWilmington, DE29 
COVANCEPrinceton, NJ27 




Nearby Competitors

These companies are similar in business line and location to Alnylam Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ALNYLAM PHARMACEUTICALSCambridge, MA100 
BLUEBIRD BIOCambridge, MA94 
BEIGENE USACambridge, MA64 
ARIAD PHARMACEUTICALSCambridge, MA59 
AGIOS PHARMACEUTICALSCambridge, MA53 
CENTOGENE USCambridge, MA44 




Future Competition: Alnylam Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Alnylam Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Alnylam Pharmaceuticals Competitors